Advertisement
Product › Details
OmniAb® technology
Next higher product group | transgenic animal technology | |
Status | 2016-03-28 sales existent | |
Organisation | Ligand Pharmaceuticals Inc. (Nasdaq: LGND) | |
Group | Ligand (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for transgenic animal technology
- [1] T-Knife Therapeutics, Inc.. (1/5/22). "Press Release: T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel". South San Francisco, CA & Paris....
- [2] T-Knife Therapeutics, Inc.. (7/12/21). "Press Release: T-Knife Therapeutics Announces the Appointment of Megan Baierlein as Chief Operating Officer". San Francisco, CA & Berlin....
- [3] T-Knife GmbH. (1/19/21). "Press Release: T-Knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer". San Francisco, CA & Berlin....
- [4] T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ....
- [5] T-Knife GmbH. (8/6/20). "Press Release: T-Knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies". Berlin....
- [6] Ligand Pharmaceuticals Inc.. (12/2/19). "Press Release: Ligand Enters into Worldwide OmniAb Platform License Agreement with Sanofi". San Diego, CA....
- [7] genOway S.A.. (6/4/19). "Press Release: genOway Announces the Consolidation of a Precompetitive Consortium to Develop and Validate Humanized Immune Checkpoint Mouse Models". Lyon....
- [8] genOway S.A.. (5/27/19). "Press Release: genOway Licenses the Flex Technology Rights to HHMI for the Distribution of Its AAV FLEX". Lyon....
- [9] genOway S.A.. (9/25/18). "Press Release: genOway Announces the Acquisition of Axenis to Create the Largest Offer of Preclinical Models in the Immuno-oncology and Immuno-inflammation Space". Lyon....
- [10] Enthera S.r.l.. (3/22/18). "Press Release: Enthera and Trianni Announce Licensing Agreement". San Francisco, CA & Milano....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top